The influence of chloroquine-dosage as comedication on the response of "non-responder" dialysispatients at Hepatitis B vaccine

The influence of chloroquine-dosage as comedication on the response of "non-responder" dialysispatients at Hepatitis B vaccine - The influence of chloroquine-admission on hepatitis B vaccine

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON29902

Enrollment

Registered

2006-10-30

Start date

2006-09-01

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

immunodeficiency renal disease

Interventions

10 patients receive on day 1 300 mg chloroquine and on day 3 an injection of Hbvaxpro 10 other patients receive on day 3 an injection of Hbvaxpro At both arms after 2 weeks the titre HbsAl will be ch

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Chronic hemodialysis patients, Terminated Hepatitis B vaccination programme Anti HbAl-titier

Exclusion criteria

Exclusion criteria: Myasthenia Gravis, Rethinopathia, Hypersensitivity of 4-aminochinolinederivates

Design outcomes

Primary

Measure	Time frame
Titre HbsAl in both arms	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)